Yoshiya Kikawa is President of Life Care Solutions Division at Terumo Corporation. He joined Terumo Corporation in 1986 and has successfully contributed to the R&D division, corporate strategic planning department, pain relief business department and Terumo’s Diabetes and Healthcare Group . Driven by his mission to alleviate pain, he used his experience to successfully provide multimodal pain relief devices to patients, to help to improve their quality of life. In the diabetes business, too, his commitment is for the patients’ benefit. His goal is to improve the QoL for as many patients as possible by providing Terumo’s valued products and services, such as MEDISAFE WITH detachable patch pump presented at this symposium.

Emma is Global Policy & Advocacy Manager for LFAC. She works with partners to encourage evidence-based advocacy initiatives that underpin the sustainable provision of adequate T1D care. Emma has been engaged in advocacy since she was diagnosed with T1D in 1999. She has witnessed firsthand the impacts that community initiatives and advancements in diabetes care have had on her own health outcomes, and believes everyone with T1D should be given the opportunity to live safe and healthy lives.

After completing his degree in medicine at the Jagiellonian University in 1994 he took up the post of clinical assistant at the Department of Metabolic Diseases in Krakow, later on was appointed as adjunct, associate and full professor. From 1999-2001 he worked as a research fellow at Joslin Diabetes Center, Harvard Medical School. His research encompasses two areas: genetics of monogenic forms of diabetes and modern technologies in diabetes treatment. He published in respected scientific journals including “Diabetes”, “Diabetes Care”, “Diabetologia”, “Nature Clinical Practice Neurology”, “Proceedings of the National Academy of Sciences USA” . Since 2014 Prof. Tomasz Klupa coordinates two chapters of the National Diabetes Guidelines published annually by Diabetes Poland (DP), he is the head of the Pump School Educational Initiative by DP. Recently Prof. Tomasz Klupa co-authored a consensus report by the American Diabetes Association and the European Association for the Study of Diabetes on the management of type 1 diabetes in adults. Current position: Professor, Head of the Center on Advanced Technologies in Diabetes, Department of Metabolic Diseases, Jagiellonian University, Krakow Poland, Board Member of Diabetes Poland, Board Member of Central European Diabetes Association, Regional Consultant in Diabetes for Lesser Poland.

Boris Kovatchev, PhD, is Professor at the University of Virginia School of Medicine and School of Engineering, and Founding Director of the UVA Center for Diabetes Technology. Kovatchev has a 30-year track record in modeling, biosimulation, and algorithm development related to the treatment of diabetes. Currently, he is Principal Investigator of several projects dedicated to diabetes data science and the development of artificial pancreas systems. Kovatchev is author of over 200 peer-reviewed publications and holds 91 U.S. and international patents, among which are algorithms behind the Control-IQ closed-loop system. For his work, in 2020, he was elected a Fellow of the National Academy of Inventors.